Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...

With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and ...

Dupilumab added to standard COPD triple therapy reduces the annual rate of moderate exacerbations but not severe exacerbations.

China: A recent multicenter randomized controlled trial has highlighted the potential benefits of acupuncture as a ...

Many people with COPD have other conditions like diabetes or high cholesterol, too. Managing several conditions can be ...

The CRYSTAL trial is the first large-scale study exploring the effects of directly switching symptomatic, non-frequently exacerbating patients with moderate COPD from their current treatments.

The worldwide increase in both COPD and diabetes cases underscores the importance of these findings. With projections indicating significant growth in affected populations, identifying treatments ...

If you’ve received a COPD diagnosis, your doctor can provide you with more accurate information about your outlook based on your individual circumstances. Advances in treatments are also helping ...

“This could influence treatment decisions and improve respiratory health in this high-risk population.” “GLP-1 medications might help lower COPD exacerbation risk by reducing systemic ...

Young COPD, referring to cases of COPD that occur in people aged 20–50 years, is often overlooked in research and clinical ...

St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive disease (COPD)/emphysema. COPD affects the lungs and their ability to ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...